The safety and effectiveness of subcutaneous NOVOLOG were compared to regular human insulin in 596 type 1 diabetes adult, 187 pediatric type 1 diabetes, and 91 adult type 2 diabetes patients using NPH as basal insulin (see Tables 3, 4, 5)
A SGLT2i + DPP4i FDC is a suitable option for Indian T2D patients, for the following reasons: Safer, rapid, and sustained glycemic control Improves both insulin resistance and beta cell function Helps reduce body weight and blood pressure (extraglycemic benefits) Reduces pill burden (adherence and compliance improves) Overall cost effective The following decision-making algorithms (Fig
Owing to the preference for a fairer complexion in many parts of the world due to personal and social reasons, there has been a huge interest in glutathione as a depigmenting agent
Metabolic adaptation is most likely the reason for this plateau [11] rather than poor response or resistance to the medication
Dose changes and pauses are handled when the patient messages the care team before the next refill, and the team is available for nonurgent clinical questions
